Andrew A. Hindman - SVP, CHIEF FINANCIAL OFFICER at Theravance Biopharma, Inc.

Issuer-level insider activity

Role
Svp, Chief Financial Officer
Issuer ticker
TBPH on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Andrew A. Hindman since 06 Oct 2025

Reported holdings for Andrew A. Hindman in Theravance Biopharma, Inc.

Form 4 holding SVP, CHIEF FINANCIAL OFFICER

Theravance Biopharma, Inc.

Security class
Ordinary Shares
Shares / value
384,714
Estimated value
$3,958,707
Report date
20 Nov 2022
Price
$10.29
Ownership
Direct

Transaction history for Andrew A. Hindman in Theravance Biopharma, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .